Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

VISX Wins FDA Approval for Treatment of Hyperopic Astigmatism

Facebook Twitter LinkedIn Email Comments
SANTA CLARA, Calif., Oct. 23 -- The US Food and Drug Administration has deemed VISX Inc.'s STAR excimer laser systems as safe and effective for the treatment of hyperopic astigmatism. VISX develops refractive laser technology for the US and other countries. : We are extremely pleased to add another FDA-approved indication to our product offering, said Liz Davila, president and COO of VISX. The ability to treat hyperopic astigmatism on the VISX STAR laser systems will benefit our customers and their patients.
Oct 2000
News & Features

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2020 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.